In addition, in patients with benign variants and patients without identified variants, testing a wider range of cardiac disease-related genes (such as FLNC, ALPK3, CDH, etc.)not included in our study would lead to greater utility of molecular analysis. Here, ALPK3 is linked to heart disorder.